About BenchSci

Scientists often spend weeks or even months sifting through research to figure out which reagents to use in specific experiments. Not only is that an inefficient process, it often doesn’t work. BenchSci’s AI-assisted platform solves this challenge by automatically ingesting and interpreting millions of historical experiments from around the world saving scientists time and money and leading to more successful experiments.

We strongly believe that opportunities within the preclinical R&D market remain largely untapped and the BenchSci team is extending the impact of its industry-leading software by driving a suite of new applications that help scientists optimize their experiment designs to maximize their chances for success.

Company Information

Headquarters: Toronto

Investment Information

Investment year: 2018

Inovia Team Members: Dennis Kavelman Mia Morisset Steven Chung

BenchSci's Journey with Inovia

Mar 2016

Inovia is introduced to BenchSci at Founder Fuel

Apr 2018

Inovia leads BenchSci’s Series A

Dec 2019

Inovia participates in the company's Series B

Sep 2021

Dennis Kavelman joins BenchSci’s Board of Directors

Nov 2021

Inovia co-leads Series C with TCV

May 2023

Inovia participates in the company's Series D


More to come!